- Home
- PAAS vs SNN Comparison
PAAS vs SNN Comparison
Compare PAAS & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PAAS | SNN |
|---|---|---|
| Founded | 1994 | 1856 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0B | 14.0B |
| IPO Year | 1995 | 1999 |
Fundamental Metrics
Financial Performance| Metric | PAAS | SNN |
|---|---|---|
| Price | $44.19 | $33.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $47.00 | $32.83 |
| AVG Volume (30 Days) | ★ 5.8M | 476.9K |
| Earning Date | 11-12-2025 | 03-02-2026 |
| Dividend Yield | 1.04% | ★ 2.19% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | ★ 1.73 | 0.56 |
| Revenue | $3,254,800,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $27.28 | $7.78 |
| Revenue Next Year | $21.01 | $5.13 |
| P/E Ratio | $29.46 | ★ $29.10 |
| Revenue Growth | ★ 21.75 | 5.35 |
| 52 Week Low | $19.80 | $23.69 |
| 52 Week High | $46.60 | $38.79 |
Technical Indicators
Market Signals| Indicator | PAAS | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 65.76 | 48.01 |
| Support Level | $43.44 | $32.68 |
| Resistance Level | $46.60 | $33.56 |
| Average True Range (ATR) | 1.84 | 0.41 |
| MACD | 0.58 | 0.14 |
| Stochastic Oscillator | 79.93 | 78.51 |
Price Performance
Historical ComparisonAbout PAAS Pan American Silver Corp.
Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.